Journal Mobile Options
Table of Contents
Vol. 10, No. 3, 2007
Issue release date: June 2007
Community Genet 2007;10:174–180

The Comprehensiveness of Family Cancer History Assessments in Primary Care

Murff H.J. · Greevy R.A. · Syngal S.
aDivision of General Internal Medicine, bDepartment of Biostatistics, Vanderbilt University Medical Center, cDepartment of Veterans Affairs, Tennessee Valley Healthcare System, GRECC, Nashville, Tenn., dDivision of Gastroenterology, Brigham and Women’s Hospital, and ePopulation Sciences Division, Dana-Farber Cancer Institute, Boston, Mass., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: Accurate family history information is required for adequate breast and colorectal cancer risk assessments. Few studies have examined the comprehensiveness of the family medical history interview in primary care. Methods: We compared family cancer history information collected through a self-completed survey with that documented within medical charts for 310 patients. Results: Forty-three percent (18/42) of individuals at increased risk for breast or colorectal cancer based on their family history had documentation of this risk within their chart. Age of cancer diagnosis was recorded for 40% (50/124) of affected relatives identified by chart review compared with 81% (203/252) identified through the survey (p < 0.0001). Conclusions: Over half of the individuals at increased risk for breast or colorectal cancer based on their family history did not have documentation of this risk within their medical record, and the age of relatives at diagnosis was frequently missing.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Rich EC, Burke W, Heaton CJ, Haga S, Pinsky L, Short MP, Acheson L: Reconsidering the family history in primary care. J Gen Intern Med 2004;19:273–280.
  2. Harrison TA, Hindorff LA, Kim H, Wines RC, Bowen DJ, McGrath BB, Edwards KL: Family history of diabetes as a potential public health tool. Am J Prev Med 2003;24:152–159.
  3. Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, Brooks D, Creasman W, Cohen C, Runowicz C, Saslow D, Cokkinides V, Eyre H, ACS Prostate Cancer Advisory Committee, ACS Colorectal Cancer Advisory Committee, ACS Endometrical Cancer Advisory Committee: American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J Clin 2001;51:38–75.
  4. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol 1996;14:1730–1736; discussion 1737–1740.
  5. Vasen HF, Watson P, Mecklin JP, Lynch HT: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116:1453–1456.
  6. Fletcher SW, Elmore JG: Clinical practice. Mammographic screening for breast cancer. N Engl J Med 2003;348:1672–1680.
  7. Shattuck-Eidens D, Oliphant A, McClure M, Gupte J, Rubano T, Pruss D, Tavtigian SV, Teng DH, Adey N, Staebell M, Gumpper K, Lundstrom R, Hulick M, Kelly M, Holmen J, Lingenfelter B, Manley S, Fujimura F, Luce M, Ward B, Cannon-Albright L, Steele L, Offit K, Thomas A: BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA 1997;278:1242–1250.
  8. Emery J, Rose P: Expanding the role of the family history in primary care. Br J Gen Pract 1999;49:260–261.
  9. Acton RT, Burst NM, Casebeer L, Ferguson SM, Greene P, Laird BL, Leviton L: Knowledge, attitudes, and behaviors of Alabama’s primary care physicians regarding cancer genetics. Acad Med 2000;75:850–852.
  10. Summerton N, Garrood PV: The family history in family practice: a questionnaire study. Fam Pract 1997;14:285–288.
  11. Hayflick SJ, Eiff MP, Carpenter L, Steinberger J: Primary care physicians’ utilization and perceptions of genetics services. Genet Med 1998;1:13–21.
  12. Acheson L, Wiesner G, Zyzanski S, Goodwin M, Strange K: Family history-taking in community family practice: implications for genetic screening. Genet Med 2000;2:180–185.
  13. Murff HJ, Byrne D, Syngal S: Cancer risk assessment quality and impact of the family history interview. Am J Prev Med 2004;27:239–245.
  14. Cpt 2003: Current Procedural Terminology, ed 4. Chicago, American Medical Association, 2002.
  15. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C: Colorectal cancer screening and surveillance: clinical guidelines and rationale – update based on new evidence. Gastroenterology 2003;124:544–560.
  16. Scheuner MT, Wang SJ, Raffel LJ, Larabell SK, Rotter JI: Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet 1997;71:315–324.
  17. Frank TS, Manley SA, Olopade OI, Cummings S, Garber JE, Bernhardt B, Antman K, Russo D, Wood ME, Mullineau L, Isaacs C, Peshkin B, Buys S, Venne V, Rowley PT, Loader S, Offit K, Robson M, Hampel H, Brener D, Winer EP, Clark S, Weber B, Strong LC, Thomas A: Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 1998;16:2417–2425.
  18. Frezzo TM, Rubinstein WS, Dunham D, Ormond KE: The genetic family history as a risk assessment tool in internal medicine. Genet Med 2003;5:84–91.
  19. Murff HJ, Byrne D, Haas JS, Puopolo AL, Brennan TA: Race and family history assessment for breast cancer. J Gen Intern Med 2005;20:75–80.
  20. Guttmacher AE, Collins FS, Carmona RH: The family history – more important than ever. N Engl J Med 2004;351:2333–2336.
  21. Blumenthal D, Causino N, Chang YC, Culpepper L, Marder W, Saglam D, Stafford R, Starfield B: The duration of ambulatory visits to physicians. J Fam Pract 1999;48:264–271.
  22. Sweet KM, Bradley TL, Westman JA: Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol 2002;20:528–537.
  23. Ebell MH, Heaton CJ: Development and evaluation of a computer genogram. J Fam Pract 1988;27:536–538.
  24. Gerson R, McGoldrick M: The computerized genogram. Prim Care 1985;12:535–545.
  25. Emery J, Walton R, Coulson A, Glasspool D, Ziebland S, Fox J: Computer support for recording and interpreting family histories of breast and ovarian cancer in primary care (RAGs): qualitative evaluation with simulated patients. BMJ 1999;319:32–36.
  26. Emery J, Walton R, Murphy M, Austoker J, Yudkin P, Chapman C, Coulson A, Glasspool D, Fox J: Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases. BMJ 2000;321:28–32.
  27. Green MJ, Fost N: An interactive computer program for educating and counseling patients about genetic susceptibility to breast cancer. J Cancer Educ 1997;12:204–208.
  28. Westman J, Hampel H, Bradley T: Efficacy of a touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment. J Med Genet 2000;37:354–360.
  29. Johnson N, Lancaster T, Fuller A, Hodgson SV: The prevalence of a family history of cancer in general practice. Fam Pract 1995;12:287–289.
  30. Hughes KS, Roche C, Campbell CT, Siegel N, Salisbury L, Chekos A, Katz MS, Edell E: Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire. Breast J 2003;9:19–25.
  31. Mitchell RJ, Brewster D, Campbell H, Porteous ME, Wyllie AH, Bird CC, Dunlop MG: Accuracy of reporting of family history of colorectal cancer. Gut 2004;53:291–295.
  32. Rauscher GH, Sandler DP: Validating cancer histories in deceased relatives. Epidemiology 2005;16:262–265.
  33. Murff HJ, Spigel DR, Syngal S: Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 2004;292:1480–1489.
  34. Medalie JH, Zyzanski SJ, Langa D, Stange KC: The family in family practice: is it a reality? J Fam Pract 1998;46:390–396.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50